-
2010
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
-
Meet us
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
Miscellaneous
Axelsen, L.N., Pedersen, H.D., Petersen, J.S., Holstein-Rathlou, N-H. and Kjølbye, A.L.
Metabolic and cardiac changes in high cholesterol–fructose-fed rats
J Pharmacol.Toxicol.Methods, 2010, 61, 292-296
Axelsen, L.N., Lademann, J.B., Petersen, J.S., Holstein-Rathlou, N.-H., Ploug, T. Prats,C., Pedersen, H.D., and Kjølbye, A.L.
Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation.
Am.J Physiol Regul.Integr.Comp Physiol, 2010, 298, R1560-R1570
Solomon, D.H.
Turning Peptides into Drug
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Oral presentation
Larsen, B.D., Verma, V. Coombs, W., Lin, X., Spagnol, G., Sorgen, P.L., Taffet, S., and Delmar, M.
Discovery of novel small peptidomimetics that prevent cardiac gap junction closure and action potential propagation block. - From a 34 amino acid peptide RXP-E to active 3 amino acid peptide mimetics
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation
Delmar, M, Lewandowski, R., Procida, K., Vaidyanathan, R., Coombs, W., Jalife, J., Nielsen, M.S., Larsen, B.D., Taffet, S.M.
RXP-E: A Cx43-binding peptide that prevents action potential propagation block
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation
Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J.S., Jørgensen, N.R., Just, R., Schwarz, P., Ramirez, M.T., Stahlhut, M.
Amylin(1-8) is Devoid of Anabolic Activity in Bone
Calcif.Tissue Int., 2010, 249-260
Easton, J.A., Petersen, J.S., and Martin, P.E.M.
The Antiarrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function
Naunyn Schmiedebergs Arch Pharmacol, 2009, 380, 11-24
Spagnol, G., Coombs, W., Taffet. E.M., Larsen, B.D., Delmar, M. and Sorgen, P.L.:
Redefining the interaction domain of Cx43CT with RXP-E and Cx43CL: a story of synthetic peptide versus recombinantly expressed peptide.
Poster at at Internatinal Gap Junction Conference, Sedona, Arizona, 25-30 July 2009
Verma, V., Larsen, B.D., Coombs, W., Lin, X., Spagnol, G., Sorgen, P., Taffet, S. and Delmar, M.:Novel pharmacophores of connexin 43 based on the “RXP” series of Cx43-binding peptides.
Presentation at Internatinal Gap Junction Conference, Sedona, Arizona, 25-30 July 2009
Verma, V., Larsen, B.D., Coombs, W., Lin, X., Spagnol, G., Sorgen, P.L., Taffet, S.M., and Delmar, M.:
Novel Pharmacophores of Connexin43 Based on the “RXP” Series of Cx43-Binding Peptides
Circ Res. 2009, 105, 176-184
Knudsen, C.B. and Jensen, A.L:
Development of an immunoaffinity purification sample preparation method prior to LC/MS/(MS) analysis for identification of peptide metabolites.
Hepatocyte Users Symposium 2009, Snekkersten, 22-23 January 2009. Abstract P5.
Poster
Doi, K., Hu, X., Yuen, P.S.T., Leelahavanichkul, A., Yasuda, H., Kim, S.M., Schnermann, J., Jonassen, T.E.N., Frøkiær, J., Nielsen, S., Star, R.A.:
AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality
Kidney International 2008, 73, 1266-1274
Larsen, B.D.:
Structure-inducing probes: Implications on synthesis, stability and pharmacological properties of peptides.
Presentation at Tides, Las Vegas, Nevada, USA, 21-23 Maj 2007.
Larsen, B.D., Knudsen, C.B., Butera, J. and Petersen, J.S.:
Discovery of novel potent and selective antiarrhythmic peptides - from AAP10 to stable, orally available small molecules.
Abstract p 94, International Gap Junction Conference, Elsinore, Denmark, 4-7 August 2007
Martin, P., Petersen, J.S. and Easton, J.:
The Antiarrhythmic peptide AAP10 enhances Cx43 and Cx40 expression and functionality by a protein kinase C dependent mechanism
Abstract p 92, International Gap Junction Conference, Elsinore, Denmark, 4-7 August 2007
Ellegaard, M., Stahlhut, M., Thorkildsen, C., Petersen, J.S., Pedersen, S., Jørgensen, N.R. and Schwarz, P.:
The effect of amylin(1-8) on bone in ovariectomized rats
Abstract for the 34th European Symposium on Calcified Tissue, Copenhagen, Denmark, 5-9 May 2007
Poster
Petersen, Y.M., Larsen, B.D., and Petersen, J.S.:
[Gly2]GLP-2 Administration Both Prior To And Concurrently With Chemotherapy Inhibits Small Intestinal Atrophy And Attenuates Body Weight Loss in Mice.
Poster at American Gastroenterological Association - Digestive Diseases Week. Chicago, Illinois, USA, May 12th-19th 2005.
Poster presentation
Petersen, Y.M., Larsen, B.D. and Petersen, J.S.:
[Gly2]GLP-2 inhibits chemotherapy-induced small intestinal atrophy and body weight loss in mice.
Poster B6 for Dansk Farmakologi 2005, 19 Januar, 2005, SDU, Odense, Denmark, Abstract
Poster presentation
Henriksen, Z., Thorkildsen, C., Jensen, J.-E.B and Jørgensen, N.R.:
PTH increases bone mineral density and resistance to mechanical load in a rat model of osteoporosis.
The American Society for Bone and Mineral Research (ASBMR), 26th meeting. Poster abstract, M486 Seattle, WA, USA, 1-5 October, 2004
J Bone Min Res 2004, 19 (Suppl 1), Poster M486, S460-S461
Poster presentation
Haugan, K., Lam, H.R., Knudsen, C.B., and Petersen, J.S.:
Atrial fibrillation in rats induced by rapid transesophageal atrial pacing during brief episodes of asphyxia. A new in vivo model.
PhysPharm 2003; Scandinavian Congress of Physiology and Pharmacology, Odense, Denmark, 11-14 October 2003.
Acta Physiol Scand, 2004, 181, A84-A85, Abstract P 02-06
Poster presentation
Haugan, K., Lam, H.R., Knudsen, C.B. and Petersen, JS:
Atrial fibrillation in rats induced by rapid transesophageal atrial pacing during brief episodes of asphyxia: A new in vivo model.
J.Cardiovasc. Pharmacol. 2004, 44,125-135
Gustafsson, F., Mikkelsen H. B., Arensbak, B., Thuneberg, L., Neve, S., Jensen, L. J., Holstein-Rathlou, N-H.:
Expression of connexin 37, 40 and 43 in rat mesentaric arterioles and resistance arteries.
Histochem Cell Biol (2003) 119:139-148
Knudsen, C.B. and Petersen, J.S.:
Determination of two GLP-1 analogues in plasma by LC/MS – A pharmacokinetic study.
Abstract/Poster to 17th (Montreux) Symposium on Liquid Chromatography/Mass Spectrometry, November 8-10, 2000, Montreux, France. Abstract no. 49.
Poster presentation
Larsen, B.D., Jensen, L.H., Mørk, N.E., Bjerrum, M.J., Meissner, A., Nielsen, G., Jensen, P.H. and Frokjaer, S.:
Structural inducing probes (SIP) – blows new hope into the general use of peptides as drugs.
Peptides 2000. Proceedings of the twenty-sixth European Peptide Symposium, September 10-15, 2000, pp 37-38.
Larsen, B.D., Jensen, L.H., Mørk, N.E., Bjerrum, M.J., Meissner, A., Nielsen, G., Jensen, P.H. and Frokjaer, S.:
Structural inducing probes (SIP) – blows new hope into the general use of peptides as drugs.
Peptides 2000. The twenty-sixth European Peptide Symposium, September 10-15, 2000. Montpellier, France.
J Peptide Science, 2000, suppl. To volume 6, S 57, abstract no. OC 01
Kjølbye, A.L., Kanters, J., Holstein-Rathlou, N.-H. and Petersen, J.S.:
The antiarrhythmic peptide HPP-5 reduces APD90 dispersion and prevents ventricular fibrillation in isolated perfused rabbit hearts.
Experimental Biology 2000, April 12-18, 2000, San Diego, California USA.
The FASEB Journal 2000, 14 (4), p A698 (Abstract no. 486.9)
Poster presentation
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010